UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of metformin on apoptosis in a breast cancer presurgical trial

British journal of cancer, 2013-11, Vol.109 (11), p.2792-2797

2013

Volltextzugriff (PDF)

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

British journal of cancer, 2013-04, Vol.108 (8), p.1593-1601

2013

Volltextzugriff (PDF)

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

Annals of oncology, 2017-02, Vol.28 (2), p.321-328

2017

Volltextzugriff (PDF)

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

The pharmacogenomics journal, 2011-04, Vol.11 (2), p.100-107

2011

Volltextzugriff (PDF)

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ

Annals of oncology, 2015-04, Vol.26 (4), p.682-687

2015

Volltextzugriff (PDF)

Response to Dominguez-Valentin M et al. 2019: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Genetics in medicine, 2020-04, Vol.22 (4), p.811-812

2020

Volltextzugriff (PDF)

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Annals of oncology, 2010-05, Vol.21 (5), p.949-954

2010

Volltextzugriff (PDF)

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

Annals of oncology, 2011-03, Vol.22 (3), p.582-587

2011

Volltextzugriff (PDF)

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Annals of oncology, 2014-03, Vol.25 (3), p.618-623

2014

Volltextzugriff (PDF)

Long-term effects of inhaled budesonide on screening-detected lung nodules

Annals of oncology, 2015-05, Vol.26 (5), p.1025-1030

2015

Volltextzugriff (PDF)

Effect of tamoxifen at low doses on ultrasensitive C‐reactive protein in healthy women

Journal of thrombosis and haemostasis, 2003-10, Vol.1 (10), p.2149-2152

2003

Volltextzugriff (PDF)

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Annals of oncology, 2013-07, Vol.24 (7), p.1859-1866

2013

Volltextzugriff (PDF)

Chemoprevention studies within lung cancer screening programmes

Ecancermedicalscience, 2015-11, Vol.9, p.597-597

2015

Volltextzugriff (PDF)

Risk of subsequentin situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinomain situ

Annals of oncology, 2015-04, Vol.26 (4), p.682-687

2015

Volltextzugriff (PDF)

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

British journal of cancer, 2001-12, Vol.85 (12), p.1838-1841

2001

Volltextzugriff (PDF)

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

Clinical cancer research, 2004-04, Vol.10 (7), p.2336-2343

2004

Volltextzugriff (PDF)

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

Breast cancer research and treatment, 2001-09, Vol.69 (1), p.21-27

2001

Volltextzugriff (PDF)

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women

Circulation (New York, N.Y.), 2002-09, Vol.106 (10), p.1224-1228

2002

Volltextzugriff (PDF)

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women

European journal of cancer (1990), 1999-04, Vol.35 (4), p.596-600

1999

Volltextzugriff (PDF)

Prevention of breast cancer: focus on chemoprevention

Recent results in cancer research, 1998, Vol.152, p.11

1998

Volltextzugriff (PDF)

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

Ecancermedicalscience, 2008-01, Vol.2, p.67-67

2008

Volltextzugriff (PDF)

Abstract P3-10-02: Presence of atypia in ductal lavage and risk of subsequent breast cancer in a prospective study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-10-02

2018

Volltextzugriff (PDF)

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study

European journal of cancer (1990), 2000-09, Vol.36, p.50-51

2000

Volltextzugriff (PDF)

The role of factors affecting worry and risk perception of breast cancer in a chemoprevention trial of tamoxifen

Annals of oncology, 2016-09, Vol.27, p.iv93

2016

Volltextzugriff (PDF)

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women

Journal of clinical oncology, 2006-01, Vol.24 (1), p.129

2006

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(180)
Tagungsberichte
(1)

Sprache

Englisch
(181)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(94)
Humans
(78)
Oncology
(76)
Female
(73)
Middle Aged
(52)
Breast Cancer
(42)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Aged
(32)
Tumors
(30)
Adult
(29)
Breast Neoplasms - Pathology
(25)
Breast Neoplasms - Drug Therapy
(24)
Gynecology. Andrology. Obstetrics
(23)
Tamoxifen
(22)
Mammary Gland Diseases
(21)
Breast Neoplasms - Prevention & Control
(19)
Chemoprevention
(19)
Double-Blind Method
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The effect of metformin on apoptosis in a breast cancer presurgical trial

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ

Response to Dominguez-Valentin M et al. 2019: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Long-term effects of inhaled budesonide on screening-detected lung nodules

Effect of tamoxifen at low doses on ultrasensitive C‐reactive protein in healthy women

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Chemoprevention studies within lung cancer screening programmes

Risk of subsequentin situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinomain situ

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women

Prevention of breast cancer: focus on chemoprevention

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

Abstract P3-10-02: Presence of atypia in ductal lavage and risk of subsequent breast cancer in a prospective study

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study

The role of factors affecting worry and risk perception of breast cancer in a chemoprevention trial of tamoxifen

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women

Suchergebnisse filtern